Linzagolix

Unassigned

New Medicines

Endometriosis-associated pain

Information

New molecular entity
ObsEva SA
ObsEva SA

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Oral GnRH receptor antagonist
Endometriosis is estimated to affect 10-15% of women of reproductive age. However, it is difficult to determine the prevalence because of the diversity of symptoms and their severity and because endometriosis may be asymptomatic [3].
Endometriosis-associated pain
Oral